Drug Shortage Report for PROPOFOL INJECTION

Last updated on 2024-01-10 History
Report ID 210580
Drug Identification Number 02244379
Brand name PROPOFOL INJECTION
Common or Proper name Propofol Injection
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) PROPOFOL
Strength(s) 10MG
Dosage form(s) EMULSION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size AIN00003 (100 mL)
ATC code N01AX
ATC description ANESTHETICS, GENERAL
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2024-05-01
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Anticipated shortage
Updated date 2024-01-10
Company comments Product remains available. Baxter continues to work to mitigate any potential supply risk. Contact your Baxter Pharmacy representative for additional information.
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2024-01-10 French Compare
v13 2024-01-10 English Compare
v12 2024-01-10 French Compare
v11 2024-01-10 English Compare
v10 2024-01-10 French Compare
v9 2024-01-10 English Compare
v8 2024-01-05 French Compare
v7 2024-01-05 English Compare
v6 2023-11-24 French Compare
v5 2023-11-24 English Compare
v4 2023-11-20 French Compare
v3 2023-11-20 English Compare
v2 2023-11-17 French Compare
v1 2023-11-17 English Compare

Showing 1 to 14 of 14